Redona Therapeutics
PrivateLast Round
Series A
Extension
May 10, 2019
Total Funding Raised
$82.75M
Company Overview
Redona Therapeutics is a biotechnology company that develops small molecule drugs targeting enzymes that regulate RNA and DNA processes to treat serious diseases like cancer and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Redona Therapeutics Comparables
Compare Redona Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| STORM Therapeutics | 82% | |
| Accent Therapeutics | 81% | |
| Expansion Therapeutics | 81% |
Redona Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 10, 2019 | ||||
| Series A | Sep 6, 2018 |
Key People
Founding team and executive leadership
Redona Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MPM Capital | Series A |
| Vertex Ventures HC | Series A |
| MPM BioImpact | Series A |
| Osage University Partners | Series A Extension |
| Astellas Venture Management | Series A |
| Sofinnova Partners | Series A Extension |
| Longwood Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 149% MoM, from 437 to 1.1K.
- May 10, 2019
$18M round led by Sofinnova Partners
Redona Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Redona Therapeutics's valuation, stock price, and market status.
Is Redona Therapeutics a public or private company?
Redona Therapeutics is a private company.
What is the current stock price of Redona Therapeutics?
Redona Therapeutics is a private company, so its shares have no public market price. Caplight tracks Redona Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Redona Therapeutics worth (valuation)?
Valuation information for Redona Therapeutics is not publicly available.
Can I buy Redona Therapeutics stock?
Redona Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Redona Therapeutics's last funding round?
Redona Therapeutics's most recent funding round was Series A Extension on May 10, 2019.
Who are the main investors in Redona Therapeutics?
Key investors in Redona Therapeutics include MPM Capital, MPM BioImpact, Sofinnova Partners.
Will Redona Therapeutics IPO soon?
No public IPO plans have been announced for Redona Therapeutics.
How can I track Redona Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Redona Therapeutics's shares on secondary markets.